# Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis

> **NCT00259298** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 12 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** teriparatide

## Key facts

- **NCT ID:** NCT00259298
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2010-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259298, "Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00259298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*